国家医保局印发两批立项指南 促进药学服务向居家患者延伸

Core Insights - The National Healthcare Security Administration (NHSA) has issued guidelines for the pricing of general treatment and pharmaceutical services, consolidating existing price items into 63 for general treatment and 10 for pharmaceutical services [1] Group 1: General Treatment Pricing - The general treatment guidelines consider the complexity and risks associated with treating pediatric patients, introducing additional charges for certain procedures like injections and catheter placements to enhance service quality for children [1] - The guidelines aim to incentivize medical institutions to improve the quality of diagnosis and treatment services for pediatric patients [1] Group 2: Pharmaceutical Services Pricing - The pharmaceutical guidelines categorize services based on application scenarios, converting clearly defined patient needs and service contents into price items, including four categories with ten specific pricing projects [1] - A new outpatient consultation fee for pharmacy services is established to encourage qualified pharmacists to provide medication guidance to patients [1] - The introduction of a home pharmaceutical service fee allows pharmacists to offer medication assessment and guidance at patients' homes, promoting pharmaceutical services for elderly and mobility-impaired patients [1] Group 3: Implementation and Future Steps - The NHSA plans to guide provincial healthcare security bureaus to develop unified pricing benchmarks based on the issued guidelines, allowing regions with pricing management authority to adjust actual prices in accordance with these benchmarks [1]